美洲 · 区域市场 · Financial Post
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 2026
For Trade and Medical Media Only CAMBRIDGE, England — Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®…
在 Financial Post 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (financialpost.com)
